8130
D. Che6rie et al. / Tetrahedron Letters 44 (2003) 8127–8130
15. Experimental:
16. General procedure for the olefination of aldehydes or
ketones:
(a) 2-(1-Chloroethylsulfanyl)benzothiazole 5: A solution
of 2-(1-ethylsulfanyl)benzothiazole 4 (2 g, 10.24 mmol) in
30 ml CH2Cl2 was heated to 45°C and then N-chlorosuc-
cinimide (2.05 g, 15.36 mmol) was added in one portion.
The mixture was stirred for 2 h at 45°C and then cooled,
washed with water and dried over MgSO4. The solvent
was removed under reduced pressure to give the title
product as an oil (2.38 g) which was used for the fluorina-
tion without any purification. 1H NMR (250 MHz,
CDCl3): l 2.06 (d, 3JHH=6.7 Hz, 3H, CH3), 6.15 (q,
3JHH=6.7 Hz, 1H, CHCl), 7.38 (t, 3JHH=7.5 Hz, 1H,
Method A: To a THF solution of 2-(1-fluoroethylsul-
fonyl)benzothiazole 6 (1 equiv.) and the appropriate car-
bonyl compound (1.05 equiv.) a 1 M solution of sodium
bis(trimethlysilyl)amide (1.1 equiv.) in THF was added
slowly at −78°C. The mixture was stirred for 2 h at −78°C
and then allowed to warm up to room temperature and
then quenched with water. The aqueous layer was
extracted with ethyl acetate and dried over MgSO4. After
solvent evaporation the crude product was purified via
recrystallization or column chromatography.
Method B: To a cold THF solution (−17°C) of 2-(1-
fluoroethylsulfonyl)benzothiazole 6 (1 equiv.) and the
appropriate carbonyl compound (1.05 equiv.) a solution
of tBuOK (1.1 equiv.) in THF was slowly added. The
resulting solution was stirred for 30 min and then
quenched by addition of aqueous ammonium chloride
solution. The reaction was worked-up in a similar man-
ner to that described for method A.
3
3
CH), 7.49 (t, JHH=7.5 Hz, 1H, CH), 7.83 (d, JHH=7.5
3
Hz, 1H, CH), 8.00 (d, JHH=7.5 Hz, 1H, CH).
(b) 2-(1-Fluoroethylsulfanyl)benzothiazole 3: A mixture of
2-(1-chloroethylsulfanyl)benzothiazole
5 (1.96 g, 8.53
mmol), anhydrous zinc bromide (2.5 g, 11.1 mmol) and
triethylamine trihydrofluoride (5.56 mL, 34.12 mmol) in
acetonitrile (30 mL), was stirred at 70°C for 6 h. The
mixture was cooled, dissolved in ethyl acetate washed
with water and dried over MgSO4. The solvent was
removed in vacuum to give the crude title product which
was used without purification (91% purity). 1H NMR
(250 MHz, CDCl3): l 1.88 (dd, 3JHH=6.5 Hz, 3JHF=20.3
Hz, 3H, CH3), 6.71 (dq, 3JHH=6.5 Hz, 2JHF=53.8 Hz,
1H, CHF), 7.38 (t, 3JHH=7.5 Hz, 1H, CH), 7.48 (t,
Methyl
(1R-cis)-3-[(E/Z)-2-fluoro-1-propenyl]-2,2-di-
methylcyclopropane-1-carboxylate 8f: Following method
B, from a solution of methyl ester 7f (668 mg, 4.28
mmol), sulfone 6 (1 g, 4.08 mmol) in THF (10 mL) and
a solution of tBuOK (502 mg, 4.48 mmol) in THF (5
mL), a mixture of alkenes 8f (607 mg; 80%) (E/Z ratio:
45/55) was obtained after purification of the crude oil by
flash column chromatography (petroleum ether/ethyl ace-
3JHH=7.5 Hz, 1H, CH), 7.83 (d, JHH=7.5 Hz, 1H, CH),
3
7.99 (d, 3JHH=7.5 Hz, 1H, CH); 19F NMR (235 MHz,
CDCl3/CFCl3): l −142.45 (dq, 3JHF=20.3 Hz, JHF
=
2
1
tate: 95/5). H NMR (250 MHz, CDCl3): l 1.19–1.21 (m,
53.8 Hz, 1F, CHF).
(c) 2-(1-Fluoroethylsulfonyl)benzothiazole 6: Crude 2-(1-
fluoroethylsulfanyl)benzothiazole was dissolved in
12H, CH3 (E,Z)), 1.62–1.70 (m, 3H, H3,H1(E), H1(Z)),
3
1.91 (d, 3JHF=16.8 Hz, 3H, CH3 (Z)), 1.92 (d, JHF
=
3
17.3 Hz, 3H, CH3 (E)), 2.12 (t, 3JHH=9.3 Hz, 1H, H3
(Z)), 3.60 (s, 6H, CO2Me (Z,E)), 4.91 (dd, 3JHF=36.7
Hz, 3JHH=9.6 Hz, 1H, CH (Z)), 5.35 (dd, 3JHF=20.7
Hz, 3JHH=8.2 Hz, 1H, CH (E)); 19F NMR (235 MHz,
CDCl3/CFCl3): l −92.5 (dq, 3JHF=20.7 Hz, 3JHF=17.3
Hz, E isomer), −103.2 (dq, 3JHF=36.7 Hz, 3JHF=16.8
CH2Cl2 and m-chloroperbenzoic acid (2.5 equiv.) was
added to this solution. The mixture was stirred overnight
at room temperature, and then washed with 1 M sodium
hydroxide solution and dried over MgSO4. The solvent
was removed under reduced pressure and the crude
product was recrystallized from methanol to give the title
product 6 (1.55 g, 75%) (mp 75–78°C). 1H NMR (250
MHz, CDCl3): l 1.92 (dd, JHF=23.2 Hz, JHH=6.5 Hz,
3H, CH3), 5.84 (dq, 2JHF=47.9 Hz, 3JHH=6.5 Hz, 1H,
CHF), 7.50–7.65 (m, 2H), 8.05 (d, 3JHH=8.0 Hz, 1H),
8.27 (d, 3JHH=7.6 Hz, 1H); 13C NMR (62.9 MHz,
CDCl3): l 12.01 (d, 2JCF=20.2 Hz, CH3), 99.35 (d,
1JCF=219.9 Hz, CF), 122.27, 125.71, 127.79, 128.35
(CH), 137.40, 152.79, 162.00; 19F NMR (235 MHz,
Hz, Z isomer). 13C NMR (62.9 MHz, CDCl3): l 4.1 (d,
2
3
3
2JCF 32.6, CH3 (E)), 14.5, 14.6 (s, CH3), 17.9 (d, JCF
=
30.1 Hz, CH3 (Z)), 28.2, 28.3 (s, C1), 28.5, 28.6 (s, CH3),
29.5 (d, 3JCF=12.6 Hz, C3 (Z)), 30.4 (d, 3JCF=9.6 Hz, C3
(E)), 51.0, 51.1 (s, OCH3), 99.5 (d, 2JCF=11 Hz, CH (E)),
100.6 (d, 2JCF=28 Hz, CH (Z)), 158.2 (d, 1JCF=249.7,
CF), 171.1 (s, CO), 171.5 (s, CO); MS (EI, 70 eV): m/z
(%) 186 (22), 156 (89), 152 (7), 141 (33), 139 (100), 113
(15), 111 (45), 93 (6); HMRS (EI) calcd for C10H15FO2
(M+): 186.106. Found: 186.099.
3
2
CDCl3/CFCl3): l −172.0 (dq, JHF=23.2 Hz, JHF=47.9
Hz, 1F, CHF); MS (EI, 70 eV): m/z (%) 245 (7), 136 (52),
108 (100), 91 (19), 47 (18); HMRS (EI) calcd for
C9H8FNO2S2 (M+): 244.998. Found: 245.005.
17. Pazenok, S.; Demoute, J. P.; Zard, S.; Lequeux, T. Patent
WO 0,240,459, 2002; Chem. Abstr. 2002, 136, 386131.